DEUTERATED IDEBENONE
Compounds of Formula I or a pharmaceutically acceptable salt thereof, are provided. Such compounds and pharmaceutical compositions comprising such compounds may be used in the treatment of a condition that is Duchenne's muscular dystrophy, Leber's hereditary optic neuropathy or multiple sc...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TUNG, ROGER D |
| description | Compounds of Formula I or a pharmaceutically acceptable salt thereof, are provided. Such compounds and pharmaceutical compositions comprising such compounds may be used in the treatment of a condition that is Duchenne's muscular dystrophy, Leber's hereditary optic neuropathy or multiple sclerosis. (see formula I)
La présente invention concerne, dans un mode de réalisation, un composé de la formule I : (I), ou un sel de qualité pharmaceutique de celui-ci, les variables présentées dans la formule I étant telles que définies dans la description. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2908929C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2908929C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2908929C3</originalsourceid><addsrcrecordid>eNrjZBBxcQ0NcQ1yDHF1UfB0cXVy9fP3c-VhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjkaWBhaWRpbOxoRVAAABEh2_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DEUTERATED IDEBENONE</title><source>esp@cenet</source><creator>TUNG, ROGER D</creator><creatorcontrib>TUNG, ROGER D</creatorcontrib><description>Compounds of Formula I or a pharmaceutically acceptable salt thereof, are provided. Such compounds and pharmaceutical compositions comprising such compounds may be used in the treatment of a condition that is Duchenne's muscular dystrophy, Leber's hereditary optic neuropathy or multiple sclerosis. (see formula I)
La présente invention concerne, dans un mode de réalisation, un composé de la formule I : (I), ou un sel de qualité pharmaceutique de celui-ci, les variables présentées dans la formule I étant telles que définies dans la description.</description><language>eng ; fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; APPARATUS THEREFOR ; CHEMISTRY ; GENERAL METHODS OF ORGANIC CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210126&DB=EPODOC&CC=CA&NR=2908929C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210126&DB=EPODOC&CC=CA&NR=2908929C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TUNG, ROGER D</creatorcontrib><title>DEUTERATED IDEBENONE</title><description>Compounds of Formula I or a pharmaceutically acceptable salt thereof, are provided. Such compounds and pharmaceutical compositions comprising such compounds may be used in the treatment of a condition that is Duchenne's muscular dystrophy, Leber's hereditary optic neuropathy or multiple sclerosis. (see formula I)
La présente invention concerne, dans un mode de réalisation, un composé de la formule I : (I), ou un sel de qualité pharmaceutique de celui-ci, les variables présentées dans la formule I étant telles que définies dans la description.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>APPARATUS THEREFOR</subject><subject>CHEMISTRY</subject><subject>GENERAL METHODS OF ORGANIC CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBxcQ0NcQ1yDHF1UfB0cXVy9fP3c-VhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjkaWBhaWRpbOxoRVAAABEh2_</recordid><startdate>20210126</startdate><enddate>20210126</enddate><creator>TUNG, ROGER D</creator><scope>EVB</scope></search><sort><creationdate>20210126</creationdate><title>DEUTERATED IDEBENONE</title><author>TUNG, ROGER D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2908929C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>APPARATUS THEREFOR</topic><topic>CHEMISTRY</topic><topic>GENERAL METHODS OF ORGANIC CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>TUNG, ROGER D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TUNG, ROGER D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DEUTERATED IDEBENONE</title><date>2021-01-26</date><risdate>2021</risdate><abstract>Compounds of Formula I or a pharmaceutically acceptable salt thereof, are provided. Such compounds and pharmaceutical compositions comprising such compounds may be used in the treatment of a condition that is Duchenne's muscular dystrophy, Leber's hereditary optic neuropathy or multiple sclerosis. (see formula I)
La présente invention concerne, dans un mode de réalisation, un composé de la formule I : (I), ou un sel de qualité pharmaceutique de celui-ci, les variables présentées dans la formule I étant telles que définies dans la description.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2908929C |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS APPARATUS THEREFOR CHEMISTRY GENERAL METHODS OF ORGANIC CHEMISTRY METALLURGY ORGANIC CHEMISTRY |
| title | DEUTERATED IDEBENONE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T07%3A42%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TUNG,%20ROGER%20D&rft.date=2021-01-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2908929C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |